Frequently Asked
Questions

COVID-19 and SARS-CoV-2 are the same virus.

The Coronavirus infection results in COVID-19 syndrome that includes coughing, sneezing, fever, pneumonia, and potentially death. Coronaviruses have been shown to induce lung damage by increasing inflammatory signaling pathways (lung airways) and extreme cytokine production.

A person exposed to the Coronavirus may not notice any symptoms for the first two weeks and then may start sneezing, coughing and develop a fever.

By the time the two-week incubation period has passed, and a person realizes they may have Coronavirus, there has already potentially been two weeks of damage to their lungs.

In some patients, lung abnormalities will harden into layers of scar tissue known as pulmonary fibrosis. That scarring stiffens the lungs, making it hard to get enough oxygen. People with pulmonary fibrosis typically suffer shortness of breath, limiting their ability to be physically active.

Given how widely the pandemic has spread, chronic lung conditions from COVID-19 could challenge many thousands of people in years to come.

No. There are differing opinions on this and most say the lung damage is permanent with others saying it lasts up to 15 years. Once a person has the Coronavirus and incurs lung damage, they are susceptible to contracting other respiratory diseases like asthma and Pneumonia.

There are currently twenty-three (23) drugs being researched to cure viral infections and their ensuing chronic inflammation and inhibit IL-6 spike protein cytokines, but none have been approved by the FDA as of 10/13/21.

Researchers, Doctors and Scientist do not have the answer yet. There are limited results that indicate the immunity from having the infection once will last, but there is also evidence that it only lasts about three months and then you can contract Coronavirus again. Be safe and protect yourself until a vaccine is available.

Astaxanthin is an antioxidant 6,000 times more potent than Vitamin C. This effect might protect lung cells from damage. Astaxanthin might also improve the way the immune system functions and make it easier to breathe.

We use the most studied brand of astaxanthin in the world for applications such as inflammation, skin health, anti-aging, muscle endurance and recovery, and eye health.

Astaxanthin is patented as an IL-6 Cytokine inhibitor to maintain lung health and an anti-inflammatory that helps people breathe easier.

WebMD also indicates these potential uses: Astaxanthin is taken by mouth for treating Alzheimer’s disease, Parkinson’s disease, stroke, high cholesterol, liver diseases, age-related macular degeneration (age-related vision loss), and preventing cancer. It is also used for metabolic syndrome, which is a group of conditions that increase the risk of heart disease, stroke and diabetes. It is also used for improving exercise performance, decreasing muscle damage after exercise, and decreasing muscle soreness after exercise. Also, astaxanthin is taken by mouth to prevent sunburn, to improve sleep, and for carpal tunnel syndrome, dyspepsia, male infertility, symptoms of menopause, and rheumatoid arthritis. Astaxanthin is applied directly to the skin to protect against sunburn, to reduce wrinkles, and for other cosmetic benefits.

CANNABIDIOL (CBD)
Cannabidiol (CBD) is a phytocannabinoid. CBD seems to prevent the breakdown of a chemical in the brain that affects pain, mood, and mental function. Preventing the breakdown of this chemical and increasing its levels in the blood seems to reduce psychotic symptoms associated with conditions such as schizophrenia. Cannabidiol might also block some of the psychoactive effects of delta-9-tetrahydrocannabinol (THC). Also, cannabidiol seems to reduce pain and anxiety.

The use of CBD among individuals for both specific health conditions and general health and well-being is widespread. CBD is being used as a specific therapy for a number of diverse medical conditions—particularly pain and inflammatory disorders, in addition to anxiety, depression, and sleep disorders. A large percentage of respondents indicate that CBD treats their condition(s) effectively in the absence of conventional medicine and with nonserious adverse effects. (Corroon, 2018).

Reference:
Corroon, J., & Phillips, J. A. (2018). A Cross-Sectional Study of Cannabidiol Users. Cannabis and cannabinoid research, 3(1), 152–161. https://doi.org/10.1089/can.2018.0006

CANNABIGEROL (CBG)
CBG (Cannabigerol) is the neutral cannabinoid which arises through decarboxylation from the acid precursor (CBGA). CBGA is an extremely important cannabinoid from which almost all other cannabinoids are formed. As a result, CBGA is also called the stem cell in cannabinoid biosynthetic pathway.

“We know that CBG shows promise as an antibacterial agent and an anti-inflammatory,” says John Huemoeller, CEO of AXIM Biotechnologies, Inc.

The potential health benefits of CBG are extensive. A non-intoxicating compound, it’s thought to help regulate mood thanks to its ability to boost anandamide, the body’s native “bliss” molecule, as well as act as a GABA reuptake inhibitor. CBG is also a potent neuroprotectant and is currently being evaluated for its ability to combat ailments like Huntington’s Disease. It also has cancer fighting properties and is a potent antibacterial that can even treat MRSA.

TERPENE IMMUNITY BLEND
Therapeutic Blends alpha-pinene (from pine needles) and beta-caryophyllene (from peppercorns) can interfere with molecules that dilate our blood vessels. Less dilation means less inflammation. Myrcene (from mangos) and linalool (from lavender) are both sedatives that support pain relief similar to CBD, while humulene (from hops) and limonene (from citrus fruit peels) act as anti-anxiety agents alongside CBG and CBC.

The combined synergy of CBD, CBG and Terpenes has become known as the Entourage Effect.

Curcumin is already approved by the US food and drug administration (FDA). Over 300 clinical trials have reported the beneficial protective effects of curcumin against various diseases including inflammatory diseases, neurological diseases, cardiovascular diseases, pulmonary disease, metabolic diseases, liver diseases, and cancers. Curcumin has shown antiviral activities against several different viruses.

Pulmonary inflammation: There is growing evidence on the inhibitory actions of curcumin on inflammatory cytokines. Curcumin blocks the essential signals regulating the expression of various pro-inflammatory cytokines. Curcumin has anti-inflammatory and anti-fibrotic effects by reducing the expression of crucial chemokines and cytokines involved in lung infection.

Pulmonary fibrosis: Pulmonary fibrosis is a devastating outcome of COVID-19 infection associated with an almost universally terminal Acute Respiratory Distress Syndrome (ARDS) in around 32% of patients infected with COVID-19. When SARSCoV-2 affects the upper and lower respiratory tract, it results in varying degrees of ARDS releasing pro-inflammatory cytokines. Curcumin has been shown to inhibit the cellular inflammatory response by attenuating the cytokine/chemokine expression.

Pulmonary oedema: Pulmonary oedema results from the accumulation of fluid in the lungs. Recently evidence shows that prophylactic application of curcumin decreased the inflammation resulting in a reduced influx of fluid in lungs of rats under hypoxia. This was through downregulation of the pro-inflammatory cytokines.

Reference:
Zahedipour, F., Hosseini, S.A., Sathyapalan, T., Majeed, M., Jamialahmadi, T., Al‐Rasadi, K., Banach, M. and Sahebkar, A. (2020), Potential effects of curcumin in the treatment of COVID ‐19 infection. Phytotherapy Research. Accepted Author Manuscript. doi:10.1002/ptr.6738

Thymoquinone (TQ) is a chief bioactive constituent of black seed oil (Nigella sativa). TQ holds promising pharmacological properties against several diseases. It exhibits outstanding antioxidant, anti-inflammatory, anticancer, and other important biological activities. TQ effectively transforms cancer progression signaling pathways. It not only improves anticancer activity of chemotherapeutic drugs but also attenuates their side effects.

In laboratory experiments in cells and in animals, it has shown anti-inflammatory and antioxidant effects, and has been studied in models of cardiovascular diseases and diabetes, neurodegenerative diseases and stroke, and cancer. A 2016 study suggests thymoquinone may have opioid tolerance-reduction effect.

Anti-inflammatory and immunomodulating properties are among the most valued in anti-asthma herbal products. Sabinsa’s Nigellin® Thymoquinone had the highest effects in suppressing the release of cytokines IL-2, IL-6 and PGE_2 in T-lymphocytes and also in monocytes hindering the expression on IL-2 and PGE_2. These are among the most active cytokines involved in asthmatic conditions. The investigators noted a positive relationship between the TQ level in the preparations and its inhibitory potency on IL-6 and PGE_2. (Sabinsa Corp, 2020).